Brought to you by 
Knopp Biosciences raises $30mm Series C round
03 Dec 2012
Executive Summary
In what appears to be its Series C round, Knopp Biosciences LLC raised $30mm from 78 participants including return backers Biogen Idec, Saturn Partners II, Kramer Capital Partners, and LaunchCyte LLC, and new investor Innovation Works. Including this latest round, the company has brought in over $56mm in financing.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Knopp Biosciences raises $30mm Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice